|
US3096248A
(en)
*
|
1959-04-06 |
1963-07-02 |
Rexall Drug & Chemical Company |
Method of making an encapsulated tablet
|
|
US3406178A
(en)
*
|
1964-02-04 |
1968-10-15 |
Monsanto Chem Australia Ltd |
Preparation of 2-substituted benzimidazoles
|
|
US3362956A
(en)
*
|
1965-08-19 |
1968-01-09 |
Sterling Drug Inc |
1-[(heterocyclyl)-lower-alkyl]-4-substituted-piperazines
|
|
US4200641A
(en)
*
|
1976-12-21 |
1980-04-29 |
Janssen Pharmaceutica, N.V. |
1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
|
|
FI791926A7
(fi)
|
1978-06-20 |
1979-12-21 |
Synthelabo |
Fenylpiperazinderivat
|
|
DE3000979A1
(de)
*
|
1980-01-12 |
1981-07-23 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
|
|
DE3126703A1
(de)
|
1981-07-07 |
1983-01-27 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Bromhexin-retardform und verfahren zu ihrer herstellung
|
|
JPS58134033A
(ja)
|
1982-02-02 |
1983-08-10 |
Fujisawa Pharmaceut Co Ltd |
医薬組成物
|
|
IT1176613B
(it)
*
|
1984-08-14 |
1987-08-18 |
Ravizza Spa |
Derivati piperazinici farmacologicamente attivi e processo per la loro preparazione
|
|
IE58370B1
(en)
|
1985-04-10 |
1993-09-08 |
Lundbeck & Co As H |
Indole derivatives
|
|
GB8607294D0
(en)
*
|
1985-04-17 |
1986-04-30 |
Ici America Inc |
Heterocyclic amide derivatives
|
|
HUT43600A
(en)
|
1985-06-22 |
1987-11-30 |
Sandoz Ag |
Process for production of new thiazole derivatives and medical compound containing those
|
|
DE3620643A1
(de)
|
1985-06-22 |
1987-01-22 |
Sandoz Ag |
Thiazole, ihre herstellung und verwendung
|
|
GB8601160D0
(en)
*
|
1986-01-17 |
1986-02-19 |
Fujisawa Pharmaceutical Co |
Heterocyclic compounds
|
|
US5036088A
(en)
*
|
1986-06-09 |
1991-07-30 |
Pfizer Inc. |
Antiallergy and antiinflammatory agents, compositions and use
|
|
JPH0784462B2
(ja)
*
|
1986-07-25 |
1995-09-13 |
日清製粉株式会社 |
ベンゾイミダゾ−ル誘導体
|
|
US4968508A
(en)
*
|
1987-02-27 |
1990-11-06 |
Eli Lilly And Company |
Sustained release matrix
|
|
US4792452A
(en)
*
|
1987-07-28 |
1988-12-20 |
E. R. Squibb & Sons, Inc. |
Controlled release formulation
|
|
GB8830312D0
(en)
*
|
1988-12-28 |
1989-02-22 |
Lundbeck & Co As H |
Heterocyclic compounds
|
|
US4954503A
(en)
*
|
1989-09-11 |
1990-09-04 |
Hoechst-Roussel Pharmaceuticals, Inc. |
3-(1-substituted-4-piperazinyl)-1H-indazoles
|
|
WO1992002215A1
(en)
|
1990-08-09 |
1992-02-20 |
Massachusetts Institute Of Technology |
Method for treating the premenstrual or late luteal phase syndrome
|
|
WO1992003167A1
(en)
|
1990-08-24 |
1992-03-05 |
Shin-Etsu Chemical Co., Ltd. |
Coating base for pharmaceutical film and production thereof
|
|
NZ241613A
(en)
*
|
1991-02-27 |
1993-06-25 |
Janssen Pharmaceutica Nv |
Highlighting intagliations in tablets
|
|
SE9100860D0
(sv)
*
|
1991-03-22 |
1991-03-22 |
Kabi Pharmacia Ab |
New use
|
|
FR2675800A1
(fr)
|
1991-04-26 |
1992-10-30 |
Rhone Poulenc Rorer Sa |
Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
|
|
WO1992019595A1
(en)
|
1991-05-07 |
1992-11-12 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
IT1251144B
(it)
*
|
1991-07-30 |
1995-05-04 |
Boehringer Ingelheim Italia |
Derivati del benzimidazolone
|
|
US5407686A
(en)
*
|
1991-11-27 |
1995-04-18 |
Sidmak Laboratories, Inc. |
Sustained release composition for oral administration of active ingredient
|
|
DE4216364A1
(de)
|
1991-12-14 |
1993-11-25 |
Thomae Gmbh Dr K |
Neue Pyridylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5225417A
(en)
*
|
1992-01-21 |
1993-07-06 |
G. D. Searle & Co. |
Opioid agonist compounds
|
|
US5492907A
(en)
*
|
1992-12-09 |
1996-02-20 |
The United States Of America As Represented By The Department Of Health & Human Services |
Antipsychotic composition and method of treatment
|
|
DE69429768T2
(de)
|
1993-04-05 |
2002-09-19 |
Competitive Technologies, Inc. |
Diagnose und behandlung von erektilen funktionsstörungen
|
|
FR2707294B1
(fr)
*
|
1993-07-06 |
1995-09-29 |
Pf Medicament |
Nouveaux dérivés de la 3,5-dioxo-(2H,4H)-1,2,4-triazine, leur préparation et leur application en thérapeutique humaine.
|
|
GB9401090D0
(en)
|
1994-01-21 |
1994-03-16 |
Glaxo Lab Sa |
Chemical compounds
|
|
WO1995034555A1
(en)
|
1994-06-14 |
1995-12-21 |
Pfizer Inc. |
Benzimidazolone derivatives with central dopaminergic activity
|
|
PT777477E
(pt)
|
1994-08-23 |
2003-03-31 |
Smithkline Beecham Plc |
Formulacoes farmaceuticas melhoradas contendo ibuprofen e codeina
|
|
ES2204932T3
(es)
|
1994-09-12 |
2004-05-01 |
Eli Lilly And Company Limited |
Moduladores serotonergicos.
|
|
JPH08143476A
(ja)
|
1994-11-18 |
1996-06-04 |
Japan Tobacco Inc |
薬物放出制御膜及び固形製剤
|
|
FR2727682A1
(fr)
|
1994-12-02 |
1996-06-07 |
Pf Medicament |
Nouveaux derives de 3,5-dioxo-(2h,4h)-1,2,4-triazines, leur preparation et leur application a titre de medicament
|
|
US5552412A
(en)
*
|
1995-01-09 |
1996-09-03 |
Pfizer Inc |
5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen2-ol compounds which are useful for treating osteoporosis
|
|
US5883094A
(en)
*
|
1995-04-24 |
1999-03-16 |
Pfizer Inc. |
Benzimidazolone derivatives with central dopaminergic activity
|
|
US5854290A
(en)
*
|
1995-09-21 |
1998-12-29 |
Amy F. T. Arnsten |
Use of guanfacine in the treatment of behavioral disorders
|
|
US6083947A
(en)
*
|
1996-01-29 |
2000-07-04 |
The Regents Of The University Of California |
Method for treating sexual dysfunctions
|
|
GB9613423D0
(en)
|
1996-06-26 |
1996-08-28 |
Lilly Industries Ltd |
Pharmaceutical compounds
|
|
US5916916A
(en)
*
|
1996-10-10 |
1999-06-29 |
Eli Lilly And Company |
1-aryloxy-2-arylnaphthyl compounds, intermediates, compositions, and methods
|
|
EP0941074B1
(en)
|
1996-11-06 |
2004-07-21 |
Wockhardt Europe Limited |
Delayed delivery system for acid-sensitive drugs
|
|
AU731349B2
(en)
*
|
1996-12-02 |
2001-03-29 |
Merck Sharp & Dohme Limited |
Use of NK-1 receptor antagonists for treating sexual dysfunctions
|
|
US5859246A
(en)
|
1997-01-30 |
1999-01-12 |
Neurogen Corporation |
1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
|
|
GB9706089D0
(en)
|
1997-03-24 |
1997-05-14 |
Scherer Ltd R P |
Pharmaceutical composition
|
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
|
SK284690B6
(sk)
*
|
1997-06-11 |
2005-09-08 |
The Procter And Gamble Company |
Ústna dávkovacia forma na zvýšenie ochrany horného tráviaceho traktu
|
|
ATE241341T1
(de)
*
|
1997-09-10 |
2003-06-15 |
Takeda Chemical Industries Ltd |
Stabilisierte pharmazeutische zusammensetzung
|
|
SE9703375D0
(sv)
|
1997-09-18 |
1997-09-18 |
Astra Ab |
A new combination
|
|
CH692199A8
(fr)
*
|
1997-10-09 |
2002-06-14 |
Cermol S.A. |
Composes pyridiques et compositions pharmaceutique
|
|
JP3724157B2
(ja)
*
|
1997-10-30 |
2005-12-07 |
コニカミノルタホールディングス株式会社 |
映像観察装置
|
|
FR2775188B1
(fr)
*
|
1998-02-23 |
2001-03-09 |
Lipha |
Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
|
|
WO1999059584A1
(en)
|
1998-05-20 |
1999-11-25 |
Schering Corporation |
Combination of phentolamine and cyclic gmp phosphodiesterase inhibitors for the treatment of sexual dysfunction
|
|
JP2002515435A
(ja)
|
1998-05-21 |
2002-05-28 |
イーライ・リリー・アンド・カンパニー |
鬱病処置のための組合せ治療
|
|
US20020151543A1
(en)
*
|
1998-05-28 |
2002-10-17 |
Sepracor Inc. |
Compositions and methods employing R (-) fluoxetine and other active ingredients
|
|
EP1085869A4
(en)
|
1998-06-11 |
2001-10-04 |
Merck & Co Inc |
Spiropiperidine derivatives as melanocortin receptor agonists
|
|
US6068846A
(en)
*
|
1998-08-05 |
2000-05-30 |
Melaleuca, Incorporated |
Methods and materials for treating depression and mood disorder
|
|
EP0982030A3
(en)
*
|
1998-08-17 |
2000-05-10 |
Pfizer Products Inc. |
2,7-substituted octahydro-pyrrolo 1,2-a]pyrazine derivatives as 5ht 1a ligands
|
|
UA67802C2
(uk)
|
1998-10-23 |
2004-07-15 |
Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. |
Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції
|
|
WO2000028993A1
(en)
|
1998-11-19 |
2000-05-25 |
Nortran Pharmaceuticals, Inc. |
Serotonin ligands as pro-erectile compounds
|
|
US6680071B1
(en)
*
|
1999-03-03 |
2004-01-20 |
R. P. Scherer Technologies, Inc. |
Opioid agonist in a fast dispersing dosage form
|
|
AU4465200A
(en)
|
1999-04-16 |
2000-11-02 |
Dr. Reddy's Research Foundation |
Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
|
|
WO2000064441A2
(en)
|
1999-04-28 |
2000-11-02 |
Respiratorius Ab |
Compound for use as a medicament for treatment of disorders involving bronchocontraction
|
|
IT1312310B1
(it)
|
1999-05-07 |
2002-04-15 |
Recordati Ind Chimica E Farma |
Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
|
|
US6579968B1
(en)
|
1999-06-29 |
2003-06-17 |
Palatin Technologies, Inc. |
Compositions and methods for treatment of sexual dysfunction
|
|
US20030055070A1
(en)
|
1999-07-01 |
2003-03-20 |
Wilma Harrison |
Phosphodiesterase type 5 (PDE5) inhibitors for the treatment of selective serotonin reuptake inhibitor (SSR) induced sexual dysfunction
|
|
US6346548B1
(en)
*
|
1999-08-16 |
2002-02-12 |
Cephalon, Inc. |
Compositions including modafinil for treatment of attention deficit hyperactivity disorder and multiple sclerosis fatigue
|
|
IT1313625B1
(it)
|
1999-09-22 |
2002-09-09 |
Boehringer Ingelheim Italia |
Derivati benzimidazolonici aventi affinita' mista per i recettori diserotonina e dopamina.
|
|
CN1396829A
(zh)
*
|
2000-02-24 |
2003-02-12 |
法玛西雅厄普约翰美国公司 |
新的药物联合形式
|
|
CN1440406A
(zh)
|
2000-06-28 |
2003-09-03 |
辉瑞产品公司 |
黑皮质素受体配体
|
|
US6960597B2
(en)
|
2000-06-30 |
2005-11-01 |
Orth-Mcneil Pharmaceutical, Inc. |
Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
|
|
US20020052370A1
(en)
|
2000-07-06 |
2002-05-02 |
Barber Christopher Gordon |
Cyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase
|
|
US20040198706A1
(en)
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
WO2002024662A1
(en)
|
2000-09-19 |
2002-03-28 |
Boehringer Ingelheim Pharma Gmbh & Ko. Kg |
New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
|
|
US6521623B1
(en)
*
|
2000-09-19 |
2003-02-18 |
Boehringer Ingelheim Pharma Kg |
N,N'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors
|
|
US6586435B2
(en)
*
|
2000-09-19 |
2003-07-01 |
Boehringer Ingelheim Pharma Kg |
Benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors
|
|
SK7242003A3
(en)
|
2000-11-22 |
2004-01-08 |
Abbott Lab |
Selective dopamine D4 receptor agonists for treating sexual dysfunction
|
|
GB0105893D0
(en)
|
2001-03-09 |
2001-04-25 |
Pfizer Ltd |
Pharmaceutically active compounds
|
|
GB0106446D0
(en)
|
2001-03-15 |
2001-05-02 |
Vernalis Res Ltd |
Chemical compounds
|
|
NZ527012A
(en)
|
2001-03-28 |
2005-03-24 |
Pfizer |
N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD
|
|
EP1256343B1
(en)
|
2001-05-11 |
2006-07-05 |
Jürgen K. Dr. Beck |
Flibanserin for the treatment of extrapyramidal movement disorders
|
|
US6627646B2
(en)
*
|
2001-07-17 |
2003-09-30 |
Sepracor Inc. |
Norastemizole polymorphs
|
|
ATE411021T1
(de)
|
2001-07-18 |
2008-10-15 |
Merck & Co Inc |
Überbrückte piperidinderivate als melanocortin- rezeptor-agonisten
|
|
EP1412028B1
(en)
|
2001-07-30 |
2007-10-17 |
Spectrum Pharmaceuticals, Inc. |
Tetrahydroindolone derivatives linked to arylpiperazines
|
|
US7183410B2
(en)
*
|
2001-08-02 |
2007-02-27 |
Bidachem S.P.A. |
Stable polymorph of flibanserin
|
|
EP1414816B1
(en)
|
2001-08-02 |
2005-02-09 |
BIDACHEM S.p.A. |
Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
|
|
US20030060475A1
(en)
*
|
2001-08-10 |
2003-03-27 |
Boehringer Ingelheim Pharma Kg |
Method of using flibanserin for neuroprotection
|
|
DE10138273A1
(de)
|
2001-08-10 |
2003-02-27 |
Boehringer Ingelheim Pharma |
Arzneimittel mit neuroprotektiver Wirkung
|
|
HUP0202719A3
(en)
|
2001-08-21 |
2006-01-30 |
Pfizer Prod Inc |
Pharmaceutical compositions for the treatment of female sexual dysfunctions
|
|
DE10149674A1
(de)
*
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
UA78974C2
(en)
|
2001-10-20 |
2007-05-10 |
Boehringer Ingelheim Pharma |
Use of flibanserin for treating disorders of sexual desire
|
|
DE10209982A1
(de)
|
2002-03-07 |
2003-09-25 |
Boehringer Ingelheim Pharma |
Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
|
|
US20040048877A1
(en)
*
|
2002-05-22 |
2004-03-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions containing flibanserin
|
|
CA2483597C
(en)
*
|
2002-05-22 |
2010-02-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
New pharmaceutical compositions containing flibanserin polymorph a
|
|
WO2004010932A2
(en)
|
2002-07-30 |
2004-02-05 |
Peter Migaly |
Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
|
|
US20040116532A1
(en)
*
|
2002-09-13 |
2004-06-17 |
Craig Heacock |
Pharmaceutical formulations of modafinil
|
|
US20040132697A1
(en)
*
|
2002-11-06 |
2004-07-08 |
Pfizer Inc. |
Treatment of female sexual dysfunction
|
|
GB0225908D0
(en)
|
2002-11-06 |
2002-12-11 |
Pfizer Ltd |
Treatment of female sexual dysfunction
|
|
US20040147581A1
(en)
*
|
2002-11-18 |
2004-07-29 |
Pharmacia Corporation |
Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy
|
|
WO2004063864A2
(en)
*
|
2003-01-06 |
2004-07-29 |
Laura Berman |
Method and system for computerized sexual function assessment of female users
|
|
US20050004105A1
(en)
*
|
2003-01-29 |
2005-01-06 |
Emer Leahy |
Treatment for a attention-deficit hyperactivity disorder
|
|
US20050037983A1
(en)
|
2003-03-11 |
2005-02-17 |
Timothy Dinan |
Compositions and methods for the treatment of depression and other affective disorders
|
|
JP2007516949A
(ja)
|
2003-07-16 |
2007-06-28 |
ファイザー・インク |
性機能不全の治療
|
|
US20050065158A1
(en)
*
|
2003-07-16 |
2005-03-24 |
Pfizer Inc. |
Treatment of sexual dysfunction
|
|
EP1670451A4
(en)
*
|
2003-09-11 |
2009-10-21 |
Xenoport Inc |
TREATMENT AND / OR PREVENTION OF URINARY INCONTINENCE AND PROMOTERS OF GABA ANALOGS
|
|
WO2005044238A1
(en)
|
2003-11-07 |
2005-05-19 |
Ranbaxy Laboratories Limited |
Modified release solid dosage form of amphetamine salts
|
|
RU2445095C2
(ru)
*
|
2004-04-22 |
2012-03-20 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Новые фармацевтические композиции для лечения сексуальных расстройств
|
|
US20050239798A1
(en)
*
|
2004-04-22 |
2005-10-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Method for the treatment of premenstrual and other female sexual disorders
|
|
US20060014757A1
(en)
*
|
2004-07-14 |
2006-01-19 |
Boehringer Ingelheim Pharmaceuticals |
Method for the treatment of anorexia nervosa
|
|
US20060025420A1
(en)
|
2004-07-30 |
2006-02-02 |
Boehringer Ingelheimn International GmbH |
Pharmaceutical compositions for the treatment of female sexual disorders
|
|
EP1789048A1
(en)
*
|
2004-09-03 |
2007-05-30 |
Boehringer Ingelheim International GmbH |
Method for the treatment of attention deficit hyperactivity disorder
|
|
CA2580170A1
(en)
*
|
2004-10-18 |
2006-04-27 |
Boehringer Ingelheim International Gmbh |
Use of a beta-3 agonist for treating complaints of the prostate and the lower urogenital tract
|
|
US20060211685A1
(en)
*
|
2005-03-04 |
2006-09-21 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of depression
|
|
CA2599937A1
(en)
*
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
|
|
WO2006096439A2
(en)
*
|
2005-03-04 |
2006-09-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment and/or prevention of schizophrenia and related diseases
|
|
EP1904182A2
(en)
*
|
2005-05-06 |
2008-04-02 |
Boehringer Ingelheim International GmbH |
Method for the treatment of drug abuse with flibanserin
|
|
US20060258640A1
(en)
*
|
2005-05-13 |
2006-11-16 |
Boehringer Ingelheim International Gmbh |
Use of Flibanserin in the treatment of chronic pain
|
|
JP2008540672A
(ja)
*
|
2005-05-19 |
2008-11-20 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
病状に起因する性的機能不全の治療方法
|
|
EP1888071A1
(en)
*
|
2005-05-19 |
2008-02-20 |
Boehringer Ingelheim International GmbH |
Method for the treatment of drug-induced sexual dysfunction
|
|
AU2006261788B2
(en)
|
2005-06-27 |
2012-05-31 |
Valeant International Bermuda |
Modified-release formulations of a bupropion salt
|
|
EP1912650B8
(en)
*
|
2005-08-03 |
2017-10-18 |
Sprout Pharmaceuticals, Inc. |
Use of flibanserin in the treatment of obesity
|
|
HU227490B1
(en)
|
2005-08-26 |
2011-07-28 |
Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag |
Sustained release pharmaceutical preparation containing carvedilol
|
|
US20070123540A1
(en)
*
|
2005-10-29 |
2007-05-31 |
Angelo Ceci |
Sexual desire enhancing medicaments comprising benzimidazolone derivatives
|
|
JP2009513604A
(ja)
*
|
2005-10-29 |
2009-04-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
月経前障害及び他の女性の性的障害治療用のベンゾイミダゾロン誘導体
|
|
US20070105869A1
(en)
*
|
2005-11-08 |
2007-05-10 |
Stephane Pollentier |
Use of flibanserin for the treatment of pre-menopausal sexual desire disorders
|
|
AU2007211101B2
(en)
|
2006-01-27 |
2013-05-02 |
Adare Pharmaceuticals, Inc. |
Drug delivery systems comprising weakly basic drugs and organic acids
|
|
CA2641917A1
(en)
*
|
2006-02-18 |
2007-08-23 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
|
|
US20090176698A1
(en)
*
|
2006-02-20 |
2009-07-09 |
Boehringer Ingelheim International Gmbh |
Benzimidazolone Derivatives for the Treatment of Urinary Incontinence
|
|
US20090247546A1
(en)
*
|
2006-02-28 |
2009-10-01 |
Boehringer Ingelheim International Gmbh |
Treatment of Prevention of Valvular Heart Disease with Flibanserin
|
|
DK2021006T3
(en)
*
|
2006-05-09 |
2015-11-23 |
Sprout Pharmaceuticals Inc |
USE OF flibanserin in postmenopausal SEXLYSTFORSTYRRELSER
|
|
ATE456369T1
(de)
|
2006-06-30 |
2010-02-15 |
Boehringer Ingelheim Int |
Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
|
|
US20090239881A1
(en)
*
|
2006-07-14 |
2009-09-24 |
Boehringer Ingelheim International Gmbh |
Combinations of Flibanserin with Caffeine, Process for Their Preparation and Use Thereof as Medicaments
|
|
US20090318469A1
(en)
|
2006-07-14 |
2009-12-24 |
Boehringer Ingelheim International Gmbh |
Use of Flibanserin for the Treatment of Sexual Disorders in Females
|
|
CL2007002214A1
(es)
*
|
2006-08-14 |
2008-03-07 |
Boehringer Ingelheim Int |
Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
|
|
EA200900264A1
(ru)
*
|
2006-08-14 |
2009-08-28 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Композиции флибансерина и способ их приготовления
|
|
JP5220746B2
(ja)
|
2006-08-25 |
2013-06-26 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
制御放出システム及びその製造方法
|
|
CA2672957C
(en)
|
2006-12-20 |
2015-04-14 |
Boehringer Ingelheim International Gmbh |
Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity
|
|
JP2010522714A
(ja)
|
2007-03-28 |
2010-07-08 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規な医薬組成物
|